Product Information
HYDROXYCHLOROQUINE 200 MG TAB is a generic product labeled by AvPAK, priced at $0.1490 per EA under NDC 50268041215. Its NADAC has been published 308 times since Nov 11, 2020.
FDA first approved this application on May 1, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
AvPAKNDC
50268041215
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROXYCHLOROQUINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210441FDA Approved
5/1/2018
TE Code
AB
On Market Since
5/15/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYCHLOROQUINE 200 MG TAB has been published 308 times since Nov 11, 2020, and over the history we have for it it has declined 54.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1490 per EA |
|---|---|
| All-time high | $0.3288 (Nov 11, 2020) |
| All-time low | $0.1399 (Nov 20, 2024) |
| 52-week high | $0.1643 |
| 52-week low | $0.1485 |
| Median price | $0.1956 |
| Average price | $0.2036 |
| Largest weekly change | -20.5% (Nov 20, 2024) |
| Weeks tracked | 308 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HYDROXYCHLOROQUINE SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROXYCHLOROQUINE 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYCHLOROQUINE 200 MG TAB, manufactured by AvPAK, is $0.1490 per EA (NDC 50268041215), effective Sep 30, 2026.
How has the price of HYDROXYCHLOROQUINE 200 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has declined 54.7%. It has been tracked across 308 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for HYDROXYCHLOROQUINE 200 MG TAB?
Since Nov 11, 2020, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has ranged from a low of $0.1399 (Nov 20, 2024) to a high of $0.3288 (Nov 11, 2020), with a median of $0.1956 per EA.
Are there cheaper alternatives to HYDROXYCHLOROQUINE 200 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROXYCHLOROQUINE 200 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROXYCHLOROQUINE 200 MG TAB?
HYDROXYCHLOROQUINE 200 MG TAB (NDC 50268041215) is labeled by AvPAK, and CMS classifies it as a generic product.